Only 34% of patients with erythema migrans >5 cm are positive for Lyme disease by a standard two-tier testing (STTT) algorithm.

The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

The introduction of immune checkpoint inhibitors (ICIs) was associated with a widening survival disparity between those with private insurance and those without health insurance.

Lifestyle interventions may improve oxidative and lipid metabolism among older adults with RA and overweight/obesity.

Individuals who report being always lonely have significantly higher predicted probability of depression. HealthDay News — Loneliness is a predictor of depression and poor health outcomes, according ...

Compared with other interventions, GNB was effective for pain relief and functional improvement among patients with knee OA.

The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity than traditional body mass index (BMI).

The denosumab biosimilars Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) are now commercially available in the US, according to Celltrion.

Frailty is highly prevalent among patients with vasculitis and is associated with adverse health outcomes and reduced HRQOL.

Stratifying body mass index (BMI) categories by waist circumference (WC) thresholds improves mortality risk prediction in postmenopausal women.

Aging is significantly related to anger in women, with most indicators of anger expression decreasing with age.

The National Institutes of Health announced it will put a limit on publisher fees for publicly funded research by Fiscal Year 2026.